Small GTPases

HTS assays for small G-proteins
The activity and regulation of small G-proteins has been shown to play an important role in the development and progression of a number of diseases such as cancer, cardiovascular disorders, inflammation, and neurological disorders. Targeting G-proteins, their regulators, and their downstream effectors is therefore becoming an important area of drug discovery. See the main G-protein page for general information about these proteins. Cytoskeleton, Inc. provides HTS format assays to measure in vivo activities of small G-proteins as well as in vitro drug discovery HTS assays for GEFs, GAPs, and G-protein - effector interactions.

 

Click on the assays listed below for more information.

GTPase_cycle_copy_1

Cytoskeleton's small G-protein products have been cited hundreds of times over the past two decades (see individual product page for a list of citations). Due to the sensitive nature of drug screening efforts not many of these publications are directly related to drug discovery. However, there are a few that are described below:

 

Surviladze et al., 2010. Identification of a small GTPase inhibitor using a high-throughput flow cytometry bead-based multiplex assay. J. Biomol. Screen. 15, 10-20.

Question 1:  I need a particular small G-protein/GEF combination for an assay, but I don't see it in Cytoskeleton’s list of products - can you provide those?

Answer 1: Yes, in most cases, Cytoskeleton, Inc. is able to accommodate custom protein purification needs, including fulfilling requests for specific G-protein/GEF combinations.  The only requirement is that an assay needs to be available for us to measure GDP/GTP exchange to confirm that the proteins are functional.  For the functional assay, we use mant-GTP in a fluorophore-based GEF assay (Cat. # BK100).  If the GTPase/GEF proteins are compatible with mant-GTP, then there should be no issues.

 

Question 2:  Which is the best assay format to develop inhibitors of small G-proteins?

Answer 2: The best assay format for developing and screening G-protein inhibitors is Cytoskeleton’s G-LISA activation assays (Cat. # BK124, BK125, BK127, BK128, BK129).  These assays use a 96 well plate format which allows anywhere from 2-96 reactions (wells) to be run at one time.  The G-LISAs use very little material per reaction (10-50 μg protein from a 3 cm plate), take less than 3 hours and provide quantitative data.  These features make G-LISAs ideal for developing inhibitors, testing different concentrations of an inhibitor, or performing inhibitor time-course experiments.  To study GEF and GAP inhibitors or characterize potential GEFs and GAPs, we offer the RhoGEF Exchange Assay Biochem Kit (Cat. # BK100) and the RhoGAP Assay Biochem Kit (Cat. # BK105).

 

For more information, click on the Documents tab above to see the datasheet, or contact Technical Support at tservice@cytoskeleton.com

We can't find products matching the selection.